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R adiofrequency (RF) catheter ablation of atrial fibrillation (AF) is an established therapy for drug-resistant paroxysmal AF (1) (2) (3) . In fact, recent guidelines include catheter ablation as a firstline therapy for specific groups of patients with AF (3). Pulmonary vein antrum isolation (PVAI) is the cornerstone of AF ablation procedures (3) (4) (5) (6) , and non-pulmonary vein (PV) foci have been established as important sources of AF (7) . In general, identifying non-PV foci is challenging during procedures mainly due to the difficulty in provoking AF. The adenosine/ adenosine triphosphate (ATP) test is reportedly useful for identifying dormancy after PV isolation (8) (9) (10) , and it can also provoke AF (11) . However, little is known about the clinical impact of ATP-provoked AF originating from non-PV foci in the context of AF ablation.
The goal of the present study was to systematically investigate the incidence and clinical significance of ATP-provoked AF originating from non-PV foci. The ablation was performed according to a strategy described previously (12, 13) . In brief, after a transseptal puncture, pulmonary venography during ventricular pacing and contrast esophagography were 
Kuroi et al. Values are mean AE SD or n (%).
AF ¼ atrial fibrillation; ATP ¼ adenosine triphosphate; CHADS2 score ¼ congestive heart failure, hypertension, age $75 years, diabetes mellitus (1 point for presence of each), and stroke/transient ischemic attack (2 points); CHA2DS2-VASc score ¼ congestive heart failure, hypertension, age $75 years, diabetes mellitus, stroke/transient ischemic attack, vascular disease, age 65 to 74 years, sex category; CI ¼ confidence interval; GFR ¼ glomerular filtration rate; HR ¼ hazard ratio; hs-CRP ¼ high-sensitivity C-reactive protein; LA ¼ left atrium; LV ¼ left ventricular; proBNP ¼ pro-B-type natriuretic peptide; SHD ¼ structural heart disease. Figure 1 .
Kuroi et al. (23) reported that 13% of ATP-induced non-PV foci were observed after PVAI. Their reported prevalence of ATP-provoked non-PV foci was considerably higher than in the present study, presumably due to the different study population. The majority of their study population were women (52% female) and the age was younger (mean 57.4 years) than in our study. Our study has shown that being female was an independent predictor of ATP-induced non-PV foci and that the location of the non-PV foci was strongly associated with the clinical outcome after the last procedure, which seems to be clinically significant.
MECHANISMS OF ATP-PROVOKED AF.
Adenosine is a purine nucleoside closely related to adenosine- The reason why ATP-provoked AF was identified more frequently in female patients is unclear from the present data. Previous large studies showed that the outcome after AF ablation was worse for female patients and speculated that non-PV foci were one of the causes of a higher recurrence rate (29, 30) . Differences in sex in cardiac autonomic regulation are well known (31) . Given that an ATP injection has a strong influence on autonomic tone, it is possible that the impact of ATP on the arrhythmia inducibility has sex differences and that residual non-PV foci after PVAI are revealed more frequently in female patients. Fourth, the ATP test was not undertaken before the PVAI, and thus the impact on the PVs was not evaluated.
CONCLUSIONS
An ATP injection under an isoproterenol infusion provoked AF originating from non-PV foci in 5.6% of patients undergoing paroxysmal AF ablation. The SVC was the origin of 38.5% of the non-PV foci revealed by ATP, which aides in identifying an arrhythmogenic SVC. ATP-provoked AF originating from the atria is a significant independent predictor associated with recurrent arrhythmias after the last procedure.
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PERSPECTIVES COMPENTENCY IN MEDICAL KNOWLEGDE:
Adenosine injection provoked AF originating from non-PV foci in 5.6% of patients undergoing paroxysmal AF ablation. The SVC was the origin of 38.5% of the non-PV foci revealed by adenosine, which aids in identifying an arrhythmogenic SVC. Moreover, adenosine-provoked AF originating from the atria was a significant independent predictor associated with recurrent arrhythmias after the last procedure. Non-PV Foci Revealed by an ATP Test
